Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Górski, S. Narod, J. Lubiński (2005)A common missense variant in BRCA2 predisposes to early onset breast cancer
Breast Cancer Research, 7
E. Grzybowska, H. Zientek, A. Jasińska, M. Rusin, P. Kozłowski, K. Sobczak, Anna Sikorska, E. Kwiatkowska, Laura Gorniak, E. Kalinowska, Beata Utracka‐Hutka, J. Włoch, E. Chmielik, W. Krzyzosiak (2000)High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer
Human Mutation, 16
C. Notredame, D. Higgins, J. Heringa (2000)T-Coffee: A novel method for fast and accurate multiple sequence alignment.
Journal of molecular biology, 302 1
D. Thompson, D. Easton (2001)Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.
American journal of human genetics, 68 2
D. Easton, A. Deffenbaugh, D. Pruss, Cynthia Frye, R. Wenstrup, K. Allen-Brady, S. Tavtigian, A. Monteiro, E. Iversen, F. Couch, D. Goldgar (2007)A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
American journal of human genetics, 81 5
A. Spurdle, J. Hopper, Xiaoqing Chen, G. Dite, J. Cui, M. Mccredie, G. Giles, Sarah Ellis-Steinborner, D. Venter, B. Newman, M. Southey, G. Chenevix-Trench (2002)The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 11 4
C. Healey, A. Dunning, M. Teare, D. Chase, L. Parker, J. Burn, J. Chang-Claude, A. Mannermaa, V. Kataja, D. Huntsman, P. Pharoah, R. Luben, D. Easton, B. Ponder (2000)A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
Nature Genetics, 26
Teresa Wagner, D. Stoppa-Lyonnet, E. Fleischmann, Daniela Muhr, S. Pagès, Therese Sandberg, V. Caux, Regina Moeslinger, G. Langbauer, Åke Borg, Peter Oefner (1999)Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
Genomics, 62 3
Karin Haraldsson, N. Loman, Qiujin Zhang, O. Johannsson, Hampus Olsson, Å. Borg (1998)BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
Cancer research, 58 7
J. Salgado, N. Zabalegui, F. García-Amigot, M. Gil, M. González, J. García-Foncillas (2005)Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population.
Oncology reports, 14 1
A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord, J. Hopper, N. Loman, Hampus Olsson, O. Johannsson, Å. Borg, B. Pasini, P. Radice, S. Manoukian, D. Eccles, N. Tang, E. Oláh, H. Anton-Culver, E. Warner, J. Lubiński, J. Gronwald, B. Górski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O. Kallioniemi, D. Thompson, Chris Evans, J. Peto, F. Lalloo, D. Evans, D. Easton (2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
American journal of human genetics, 72 5
D. Palli, M. Falchetti, G. Masala, R. Lupi, F. Sera, C. Saieva, C. D'amico, M. Ceroti, P. Rizzolo, M. Caligo, I. Zanna, L. Ottini (2007)Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy
BMC Cancer, 7
Kangjian Wu, S. Hinson, A. Ohashi, Daniel Farrugia, Patrícia Wendt, S. Tavtigian, A. Deffenbaugh, D. Goldgar, F. Couch (2005)Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Cancer research, 65 2
B. Csókay, N. Udvarhelyi, Z. Sulyok, I. Besznyák, S. Ramus, B. Ponder, E. Oláh (1999)High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.
Cancer research, 59 5
D. Goldgar, D. Easton, A. Deffenbaugh, A. Monteiro, S. Tavtigian, F. Couch (2004)Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
American journal of human genetics, 75 4
E. Kwiatkowska, M. Teresiak, K. Lamperska, A. Karczewska, D. Brȩborowicz, M. Stawicka, D. Godlewski, W. Krzyzosiak, A. Mackiewicz (2001)BRCA2 germline mutations in male breast cancer patients in the Polish population
Human Mutation, 17
G. Bignell, G. Micklem, Michael Stratton, A. Ashworth, R. Wooster (1997)The BRC repeats are conserved in mammalian BRCA2 proteins.
Human molecular genetics, 6 1
T. Distelman-Menachem, T. Shapira, Y. Laitman, B. Kaufman, F. Barak, S. Tavtigian, E. Friedman (2008)Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women
Familial Cancer, 8
PL Chen, CF Chen, Y Chen (1998)The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment
Proc Natl Acad Sci USA, 95
G. Chodick, J. Struewing, E. Ron, J. Rutter, J. Iscovich (2008)Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
European journal of medical genetics, 51 2
M. Thomassen, T. Hansen, Å. Borg, Henriette Lianee, F. Wikman, Inge Pedersen, Marie Bisgaard, F. Nielsen, T. Kruse, A. Gerdes (2008)BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
Acta Oncologica, 47
F. Couch, Michele Johnson, K. Rabe, K. Brune, M. Andrade, M. Goggins, H. Rothenmund, S. Gallinger, A. Klein, G. Petersen, R. Hruban (2007)The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Cancer Epidemiology Biomarkers & Prevention, 16
T. Hansen, M. Bisgaard, L. Jønson, A. Albrechtsen, B. Filtenborg-Barnkob, H. Eiberg, B. Ejlertsen, F. Nielsen (2008)Novel de novo BRCA2 mutation in a patient with a family history of breast cancer
BMC Medical Genetics, 9
A. Davies, J. Masson, M. McIlwraith, A. Stasiak, A. Stasiak, A. Venkitaraman, S. West (2001)Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.
Molecular cell, 7 2
Phang-lang Chen, Chi Chen, Yumay Chen, Jun Xiao, Z. Sharp, Wen-Hwa Lee (1998)The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.
Proceedings of the National Academy of Sciences of the United States of America, 95 9
A. Jakubowska, Katarzyna Nej, T. Huzarski, Rodney Scott, J. Lubiński (2002)BRCA2 gene mutations in families with aggregations of breast and stomach cancers
British Journal of Cancer, 87
Identification of mutations in the BRCA2 gene and estimation of their clinical consequences for women and men treated in the Maria Sklodowska-Curie Memorial Cancer Center Warsaw, Poland in the years 1998–2008. The probands (97 women and 8 men) had a family history of breast and ovarian cancer (median age 46). The presence of molecular changes was examined in DNA isolated from peripheral blood lymphocytes. Germline mutations in 27 exons of the BRCA2 gene were screened by ‘touchdown’ PCR amplification, DHPLC and sequencing. Missense mutations were classified by multiple-sequences alignments of orthologous BRCA2 protein sequences with T-Coffee software. 39 molecular changes (8 novel) were identified in the BRCA2 gene in 105 investigated patients. In 12 patients the following pathogenic mutations were identified: 5467insT, 6174delT, 6192delAT, 6675delTA, 8141del5, 9152delT, 9326insA, 9631delC, IVS23-2A > G and E394X. The presence of 10 missense type mutations was detected including the following: D1420O, T1915 M, N3124I. The determination of pathogenic status of molecular variants detected in BRCA2 gene, described in the BIC mutation database as ‘UV’ depends on many parameters. Important is the assessment of the evolutionary conservation of their protein sequences and studying of the frequency of molecular variants detected in breast cancer patients and in population. A high diversity was found of the pathogenic mutations detected in BRCA2 gene in the Polish population.
Familial Cancer – Springer Journals
Published: Apr 10, 2010
Access the full text.
Sign up today, get DeepDyve free for 14 days.